California Public Employees Retirement System’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-68,400
Closed -$1.46M – 2669
2021
Q1
$1.46M Sell
68,400
-6,321
-8% -$183K ﹤0.01% 2240
2020
Q4
$2.22M Buy
74,721
+4,921
+7% +$125K ﹤0.01% 1929
2020
Q3
$1.51M Buy
69,800
+1,800
+3% +$41.3K ﹤0.01% 1989
2020
Q2
$1.52M Buy
68,000
+2,573
+4% +$50.2K ﹤0.01% 1953
2020
Q1
$996K Buy
65,427
+20,400
+45% +$365K ﹤0.01% 2017
2019
Q4
$1.03M Buy
45,027
+33,985
+308% +$755K ﹤0.01% 2352
2019
Q3
$238K Buy
+11,042
New +$237K ﹤0.01% 2848

Other funds holding RYTM

California Public Employees Retirement System's RYTM Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2021, closing a stake of 68,400 shares — an estimated $1.46M sold.

California Public Employees Retirement System first reported a position in RYTM in Q3 2019 and held it in 7 quarters. The position peaked at $2.22M in Q4 2020. 105 funds tracked by Wall St. Rank hold RYTM as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Rhythm Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 68,400 Rhythm Pharmaceuticals shares in Q2 2021, an estimated $1.46M.
  • California Public Employees Retirement System first reported a position in Rhythm Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • California Public Employees Retirement System's Rhythm Pharmaceuticals position peaked at $2.22M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.